Coya Therapeutics, Inc. Common Stock (COYA) is a publicly traded Healthcare sector company. As of August 8, 2026, COYA trades at $4.84 with a market cap of $107.43M and a P/E ratio of -4.84. COYA moved +5.02% today. Year to date, COYA is -14.87%; over the trailing twelve months it is -21.15%. Its 52-week range spans $3.71 to $8.29. Analyst consensus is strong buy with an average price target of $15.25. Rallies surfaces COYA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for COYA shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $4.84 |
| Market Cap | $107.43M |
| P/E Ratio | -4.84 |
| EPS | $-0.98 |
| Dividend Yield | 0.00% |
| 52-Week High | $8.29 |
| 52-Week Low | $3.71 |
| Volume | 138.34K |
| Avg Volume | 0 |
| Revenue (TTM) | $3.55M |
| Net Income | $-14.88M |
| Gross Margin | 0.00% |
4 analysts cover COYA: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $15.25.